Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | thioredoxin reductase | 0.0254 | 0.9588 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0254 | 0.9588 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0254 | 0.9588 | 1 |
Brugia malayi | glutathione reductase | 0.0254 | 0.9588 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0254 | 0.9588 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0254 | 0.9588 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0088 | 0.1424 | 0.5 |
Mycobacterium tuberculosis | Probable ATP synthase a chain AtpB (protein 6) | 0.0262 | 1 | 1 |
Treponema pallidum | NADH oxidase | 0.0088 | 0.1424 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0254 | 0.9588 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0088 | 0.1424 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | ATP synthase F0F1 subunit A | 0.0262 | 1 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0254 | 0.9588 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0088 | 0.1424 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0254 | 0.9588 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0254 | 0.9588 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0254 | 0.9588 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0088 | 0.1424 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0254 | 0.9588 | 1 |
Schistosoma mansoni | ATP synthase F0 subunit 6 | 0.0262 | 1 | 1 |
Mycobacterium ulcerans | F0F1 ATP synthase subunit A | 0.0262 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0254 | 0.9588 | 0.952 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0088 | 0.1424 | 0.1234 |
Leishmania major | trypanothione reductase | 0.0254 | 0.9588 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0254 | 0.9588 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.96 | Inhibition of human ERG | ChEMBL. | 21185626 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.